Thoracic aortic aneurysm (TAA) has a prevalence of 0.16%-0.34% and an incidence of 7.6
per 100,000 person-years, accounting for 1%-2% of all deaths in Western countries …

Marfan syndrome (MFS) is the most prevalent inherited connective tissue disorder, still
remains uncurable, and is characterized by high mortality at early age driven by dissection …

Background: Aging-associated vascular and cerebrovascular dysfunction is prevalent in
many connective tissue disorders. Marfan syndrome (MFS) is the most common …

目的探讨某些药物以及所涉及的基因引起马凡综合征的可能机制. 方法通过比较毒理基因组学
数据库(CTD) 分析引起马凡综合征关联的药物及其相互作用的基因. 选取药物与马凡综合征高度 …

In dieser Arbeit wurde die Bedeutung von Myeloperoxidase (MPO) für die Entstehung von
Aortenaneurysmen im Rahmen des Marfan-Syndroms untersucht. Das Marfan-Syndrom ist …

Background: Marfan Syndrome (MFS) is a monogenic multisystem disorder resulting from
mutations in fibrillin-1, resulting in thoracic aortic aneurysm. Currently, effective treatments …

We hypothesized that there was differential vasomotor dysfunction in the microcirculation
between nondialyzed and dialyzed chronic kidney disease (CKD) patients. During live …

Marfan syndrome is a rare connective tissue disorder with a prevalence of approximately 2
to 3 per 10,000 individuals. There have been some reports of young patients with Marfan …

Marfan syndrome (MFS), a connective tissue disorder caused by mutations in the fibrillin-1
gene (FBN1), leads to progressive aortic root aneurysm. With no cure, MFS management …